Virax Biolabs Group Limit...

1.12
0.02 (2.01%)
At close: Apr 02, 2025, 3:59 PM

Virax Biolabs Stock Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for VRAX stock have an median target of 3, with a low estimate of 3 and a high estimate of 3. The median target predicts an increase of 167.86% from the current stock price of 1.12.

Target Low Average Median High
Price $3 $3 $3 $3
Change 167.86% 167.86% 167.86% 167.86%

Latest Analyst Insight Report

According to 1 stock analyst, the rating for Virax Biolabs Group Limited is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Mar 25
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
8M
from 156.42K
Increased by 5.01K%
Revenue Next Year
13.49M
from 8M
Increased by 68.7%
EPS This Year
-0.6
from -3.36
Increased by 82.1%
EPS Next Year
0.4
from -0.6
Increased by 33.3%